KAT8/MOF-Mediated Anti-Cancer Mechanism of Gemcitabine in Human Bladder Cancer Cells.

导出 OA

翻译打印收藏纠错

第一作者： Huihui,Zhu

第一单位： School of Life Sciences, Jilin University, Jilin 130012, China.

作者： Huihui,Zhu ^[1] ; Yong,Wang ^[2] ; Tao,Wei ^[1] ; Xiaoming,Zhao ^[3] ; Fuqiang,Li ^[4] ; Yana,Li ^[1] ; Fei,Wang ^[5] ; Yong,Cai ^[1] ; Jingji,Jin ^[1]

作者单位： School of Life Sciences, Jilin University, Jilin 130012, China. ^[1] Urology Department, Jilin Province People's Hospital, Jilin 130021, China. ^[2] Central laboratory, China-Japan Union Hospital of Jilin University, Jilin 130031, China. ^[3] School of Pharmacy, Changchun University of Chinese Medicine, Jilin 130117, China. ^[4] Department of Ophthalmology and Otorhinolaryngology, Changchun Children's Hospital, Jilin 130061, China. ^[5]

关键词 Bladder cancer Chemotherapy Gemcitabine KAT8/MOF

DOI 10.4062/biomolther.2020.111

PMID 33041265

发布时间 2021-03-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Biomolecules & therapeutics

2021年29卷2期

184-194页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

KAT8/MOF-Mediated Anti-Cancer Mechanism of Gemcitabine in Human Bladder Cancer Cells.

Biomolecules & therapeutics

相似文献

Biomolecules & therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

KAT8/MOF-Mediated Anti-Cancer Mechanism of Gemcitabine in Human Bladder Cancer Cells.

Biomolecules & therapeutics

相似文献

Biomolecules & therapeutics

相关期刊

检索历史清除